Cell death regulation in the precision treatment of colorectal cancer

9:30 AM Eastern Time (8:30CT, 7:30 MT, 6:30 PT), Thur. May 12, 2022

9:30-10:00 AM Prerecorded lecture (available to registrants for 30 days since the lecture).

10:00-10:30 AM Q&A, and interview about career development and scientific discoveries.

Venue: Join Zoom Meeting https://rutgers.zoom.us/j/8499671480?pwd=NktWN3BqWWNuZXBtMzk5Y3ZIWnJHUT09

Meeting ID: 849 967 1480
Password: 6096833

Lin Zhang, PhD, is a tenured Professor at University of Pittsburg Medical Center (UPMC). His research interests include designing and conducting molecular, cellular, and animal studies to determine the mechanisms of colorectal cancer therapy and prevention. His research has been continuously supported by National Cancer Institute (NCI) since 2004. He has authored over 130 research and review articles with over 25,000 citations and H-index of 60. He served as a standing member of the NIH Drug Development and Pharmacology (DMP) study section, and a member of the AACR (American Association for Cancer Research) Special Conferences Committee. He is on the editorial boards of Cancer Research and other journals and the president of ACACR (2021-2023).

Moderator: Wenwei Hu, PhD, Rutgers Cancer Institute of New Jersey.

Penn Medicine Princeton Health is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians. Penn Medicine Princeton Health designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you have a disability that may require special assistance, please contact Janis Puleio, CME Coordinator at (609) 853-7450.

Sponsor: 91360.AI, LLC and Princeton Medical Center;

Princeton Biomedical Seminars